welcome
Our goal is to understand how different flavors of receptor triggered Ras signals drive normal developmental processes of various cell types and organ systems and how (and why) perturbations of Ras-kinase signals cause human disease.
We take a very collaborate approach and integrate different research disciplines into our research program. We study cell-cell communication with biochemical assays in cell lines, with mouse models, and with organoids from patient samples. We strive to obtain entirely new insights into the mechanisms that underlie autoimmune diseases, leukemia, carcinomas, and COVID-19.
We take a very collaborate approach and integrate different research disciplines into our research program. We study cell-cell communication with biochemical assays in cell lines, with mouse models, and with organoids from patient samples. We strive to obtain entirely new insights into the mechanisms that underlie autoimmune diseases, leukemia, carcinomas, and COVID-19.
latest news
We are grateful for the financial support from the following agencies:
- NIH/NIAID (P01 Program Project - AI091580)
- NIH/NIAID (R01 - AI104789)
- NIH/NCI (R01 - CA187318)
- NIH/NHLBI (R01 - HL120724)
- Mark Foundation for Cancer Research (Momentum Fellow)
- ImmunoX CoProject Funds
- COVID-19 Administrative Supplement
- Mark Foundation for Cancer Research (Endeavor Award)